San Francisco-based HMD Labs, a developer of technology solutions for medical device firms, announced the official launch of NeuronSphere suite.
HMD Labs has spent the past 15 months developing a solution in response to the increasing demand for streamlined medical device development. This platform is a complete ecosystem of components, tools, and SaaS services – optimized for intelligent medical device firms, with security and compliance in mind.
“Edge AI/ML in medical device development is a fast-growing space, as medical devices approved by the FDA increased by 28% between 2019 and 2020. This growth is expected to continue with the global market for intelligent medical devices reaching $734.39 billion by 2027. When we get to work early with our clients, we routinely replace over 15 different SaaS point solutions, alleviating that financial and administrative burden for forward-thinking firms,” explains Kevin Derr, co-founder and CEO of HMD Labs.
HMD Labs provides a purpose-built, turnkey, high-value data analytics platform, especially for next-generation medical device developers.
Brian Greene, co-founder and chief technology officer, says, “If ‘data is the new oil,’ NeuronSphere is your refinery. Intelligent medical device startups share a goal. We turn this goal into new products and clinical value streams.”
“This specialized platform helps our clients perform foundational data analysis and data visualization so they can get to market more quickly,” Greene says. “They can allocate more of their limited resources to unique device feature development, rather than what has rapidly become the ‘table stakes’ of advanced machine learning and AI. Our platform-and-toolkit approach frees innovators from these burdens so they can focus on quickly solving their specific clinical challenges.”
NeuronSphere provides the controls, security, and compliance needed for medical device development. In addition, it accelerates value cycles from high-complexity data, optimizing cost and performance by enabling all aspects of a Data Mesh architecture. NeuronSphere streamlines compliance with FDA, GxP, SaMD, GDPR, and global data sovereignty and tenancy demands, while ensuring companies can deliver with agility and maintain ironclad control of the cloud data platform.
Latest from Today's Medical Developments
- Children’s National, FDA collaborate to advance pediatric device regulatory tools
- LK Metrology’s eco-friendliness CMMs
- Two patents for microfluidic valves
- AMADA WELD TECH’s blue diode laser technology
- Post-IMTS decline in manufacturing technology orders blunted
- ARS Automation’s FlexiBowl 200
- LMA Consulting urges businesses to restructure supply chains now
- Walter’s WEP01C indexable inserts